Cohen & Steers names Andrew Shin to lead S.Korea institutional business
US-based investment firm Cohen & Steers Inc. has appointed Andrew Shin, a 20-year veteran of the institutional investment market, as vice presid...
Affinity, GIC sell out of Kyobo Life; Chairman Shin seeks holding firm, M&A
Affinity Equity Partners and Singapore’s sovereign wealth fund GIC have sold their entire stake in Kyobo Life Insurance Co., exiting from thei...
Kyobo Life’s Shin in talks with Affinity, GIC over exits below purchase price
Kyobo Life Insurance Co., South Korea’s third-largest life insurer, is in talks with some of its financial investors (FIs) to help them exit f...
Shin & Kim’s Jeong Hae Sung named Korea’s most influential M&A lawyer
Jeong Hae Sung, a partner at Shin & Kim, topped the list of South Korea’s 10 most influential M&A lawyers after advising on a total of...
Former FSC chief Shin Je-yoon likely to be tapped as Samsung board chair
Shin Je-yoon, former chairman of South Korea’s top financial regulator, the Financial Services Commission (FSC), will likely assume the role o...
MBK Partners’ vice chair vows to hike Korea Zinc’s value to $20.6 billion
The battle over Korea Zinc Inc.'s management control between Korea Zinc Chairman Choi Yun-birm and the Young Poong Corp.-MBK Partners alliance has b...
Korea Zinc, MBK-Young Poong alliance to fight over cumulative voting
The battle over Korea Zinc Inc.'s management control between Korea Zinc Chairman Choi Yun-birm and the Young Poong Corp.-MBK Partners alliance has n...
Hanmi Pharm’s chair poised to win management feud with her son
Hanmi Pharmaceutical Group Chairman Song Young-sook is poised to claim victory in a year-long dispute with her eldest son Lim Jong-yoon to take cont...
MBK, Young Poong close in on majority of Korea Zinc
A consortium of MBK Partners and Young Poong Corp. has raised its stake in Korea Zinc Inc. to 46.7% of voting shares, drawing the group closer to ma...
Nongshim captures young consumers in Indonesia
South Korea's instant noodle giant Nongshim Co. said on Tuesday it held Shinsational Day event in Jakarta, Indonesia. On November 15, Nongshim ...
Lotte replaces 21 CEOs, slashes executive jobs by 22% in drastic reshuffle
South Korea’s retail-to-chemical conglomerate Lotte Group on Thursday replaced 21 chief executives across its affiliates and slashed executive...
La Defense might have a say over Hanmi Pharm's family feud
La Defense Partners is expected to exercise a casting vote over the ongoing management dispute at Hanmi Science Co. after the Seoul-based private eq...
Must Asset calls on Young Poong to take steps to boost shareholder value
South Korea’s Young Poong Corp., embroiled in a fierce management control dispute with Korea Zinc Inc., is now the target of an activist fund ...
Samsung Biologics wins $668 million CDMO deal with European pharma
Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...
South Korea approves Korea Zinc’s precursor as national core technology
South Korea has designated Korea Zinc Inc.'s precursor manufacturing process as a national core technology and advanced industrial technology, effec...
Korea’s Nongshim to mesmerize New Yorkers with Han River Shin Ramyun
If you’re in New York City this weekend, be sure to drop by the Korean Cultural Center.The South Korean government office has partnered with t...
MSCI Korea Index adds Hyundai Rotem
MSCI announced on Wednesday that South Korea's Hyundai Rotem Co. will be added to the Morgan Stanley Capital International (MSCI) Korea Index. ...
Korea Zinc takes control of key shareholder in management feud with MBK
Korea Zinc Inc. succeeded in taking control of Young Poong Precision Corp., a key player in the management battle against North Asia-focused private...
MBK wins enough stake in tender offer to control Korea Zinc
North Asia-focused private equity firm MBK Partners Ltd. has secured a large enough stake in Korea Zinc Inc. through a tender offer to take control ...
Korea Zinc ups share buyback price, volume to counter MBK
Korea Zinc Inc. said on Friday it will buy back more shares at a higher price than originally planned to counter North Asia-focused private equity f...
MBK not to raise Korea Zinc tender offer price after regulator warning
MBK Partners will not raise its tender offer prices again for Korea Zinc Inc. and its affiliate Young Poong Precision Corp. after hiking them twice ...
Korea Zinc, Bain Capital offer $2.4 bn share buyback vs MBK
Korea Zinc Inc. said on Wednesday it will buy back shares for 3.1 trillion won ($2.4 billion) with the backing of Bain Capital to counter MBK Partne...
MBK ups Korea Zinc bid price as management feud intensifies
North Asia-focused private equity firm MBK Partners Ltd. has raised its bid price to take control of Korea Zinc Inc. by 13.6%, increasing the cost f...
MBK, Young Poong seek $1.5 bn hostile bid for Korea Zinc
MBK Partners Ltd., the North Asia-focused private equity firm, is set to take over Korea Zinc Inc. through an up to 2 trillion won ($1.5 billion) ho...
Lotte to foster Pepero as global brand by 2035: Chairman Shin
Lotte Group has selected Pepero — a thin chocolate-covered stick cookie — as the first brand that it will foster into one of the world&r...
BGF Retail’s CU looks beyond Kazakhstan deep into Central Asia
Kazakhstan, a Central Asian country 27 times the area of South Korea, did not have any modernized convenience stores until early this year.The count...
NPS signals more say in Hanmi Pharmaceutical's family feud
South Korea’s National Pension Service is indicating more active involvement in the management of Hanmi Pharmaceutical Group embroiled in a ye...
Celltrion scraps merger with Celltrion Pharm
South Korea’s largest biosimilar maker Celltrion Inc. said on Friday that it has scrapped a plan to merge with Celltrion Pharm Inc., an R&...
Lotte leader Shin Dong-bin stresses pivot to AI-centered innovation
Shin Dong-bin, chairman of South Korea’s retail, food and chemicals conglomerate Lotte, on Friday urged affiliate executives to ramp up effort...
GC Biopharma sells HK subsidiary to CR Pharm Group for $254 mn
South Korea’s GC Biopharma Corp. announced on Wednesday that it signed a share purchase agreement (SPA) to sell all its shares in its Hong Kon...
